{"timestamp": 1771609127.9406557, "value": {"ticker": "CHRS", "company_name": "Coherus Oncology, Inc.", "short_name": "Coherus Oncology, Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 201733728, "float_shares": 108522830, "shares_outstanding": 120871013, "short_ratio": 9.22, "short_percent_of_float": 0.2542, "shares_short": 29597546, "shares_short_prior": 29066312, "insider_percent_held": 0.15016, "institution_percent_held": 0.34794, "total_cash": 191663008, "total_debt": 54320000, "total_revenue": 277728000, "revenue_growth": 0.912, "earnings_growth": 0, "profit_margins": 0.55799997, "gross_margins": 0.56308, "operating_margins": -3.6499, "debt_to_equity": 61.886, "current_ratio": 1.238, "book_value": 0.755, "price_to_book": 2.210596, "operating_cashflow": -90189000, "free_cashflow": 29647500, "price": 1.669, "52w_high": 2.616, "52w_low": 0.71, "avg_volume": 2003805, "avg_volume_10d": 2467950, "full_time_employees": 158, "audit_risk": 9, "overall_risk": 10}}